Atatreh N, Mahgoub R, Ghattas M
J Enzyme Inhib Med Chem. 2025; 40(1):2460045.
PMID: 39912405
PMC: 11803818.
DOI: 10.1080/14756366.2025.2460045.
Yaghi R, Wylie D, Andrews C, Dickert O, Ram A, Iverson B
ACS Bio Med Chem Au. 2024; 4(6):280-290.
PMID: 39712205
PMC: 11659887.
DOI: 10.1021/acsbiomedchemau.4c00045.
Navacchia M, Cinti C, Marchesi E, Perrone D
Molecules. 2024; 29(22).
PMID: 39598790
PMC: 11596935.
DOI: 10.3390/molecules29225403.
Diogo M, Cabral A, de Oliveira R
Pathogens. 2024; 13(10).
PMID: 39452697
PMC: 11510351.
DOI: 10.3390/pathogens13100825.
Sagmeister P, Melnizky L, Williams J, Kappe C
Chem Sci. 2024; 15(31):12523-12533.
PMID: 39118626
PMC: 11304546.
DOI: 10.1039/d4sc01703j.
Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.
Mia M, Howlader M, Akter F, Hossain M
Clin Pathol. 2024; 17:2632010X241263054.
PMID: 39070952
PMC: 11282570.
DOI: 10.1177/2632010X241263054.
Fixing the Achilles Heel of Pfizer's Paxlovid for COVID-19 Treatment.
Brewitz L, Schofield C
J Med Chem. 2024; 67(14):11656-11661.
PMID: 38967233
PMC: 11284777.
DOI: 10.1021/acs.jmedchem.4c01342.
Generalized open-source workflows for atomistic molecular dynamics simulations of viral helicases.
Raubenolt B, Blankenberg D
Gigascience. 2024; 13.
PMID: 38869150
PMC: 11170216.
DOI: 10.1093/gigascience/giae026.
High-Resolution Substrate Specificity Profiling of SARS-CoV-2 M; Comparison to SARS-CoV M.
Yaghi R, Andrews C, Wylie D, Iverson B
ACS Chem Biol. 2024; 19(7):1474-1483.
PMID: 38865301
PMC: 11267570.
DOI: 10.1021/acschembio.4c00096.
On the origins of SARS-CoV-2 main protease inhibitors.
Janin Y
RSC Med Chem. 2024; 15(1):81-118.
PMID: 38283212
PMC: 10809347.
DOI: 10.1039/d3md00493g.
Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV-2 M Inhibitors.
Jacobs L, van der Westhuyzen A, Pribut N, Dentmon Z, Cui D, DErasmo M
ACS Med Chem Lett. 2023; 14(10):1434-1440.
PMID: 37849558
PMC: 10577883.
DOI: 10.1021/acsmedchemlett.3c00335.
Taking stock of the mutations in human SARS-CoV-2 spike proteins: From early days to nearly the end of COVID-19 pandemic.
Guruprasad L, Naresh G, Boggarapu G
Curr Res Struct Biol. 2023; 6:100107.
PMID: 37841365
PMC: 10569959.
DOI: 10.1016/j.crstbi.2023.100107.
Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives.
Citarella A, Dimasi A, Moi D, Passarella D, Scala A, Piperno A
Biomolecules. 2023; 13(9).
PMID: 37759739
PMC: 10647625.
DOI: 10.3390/biom13091339.
Selective, broad-spectrum antiviral photodynamic disinfection with dicationic imidazolyl chlorin photosensitizers.
Arnaut Z, Pinto S, Aroso R, Amorim A, Lobo C, Schaberle F
Photochem Photobiol Sci. 2023; 22(11):2607-2620.
PMID: 37755667
DOI: 10.1007/s43630-023-00476-4.
Antiviral Activity against SARS-CoV-2 of Conformationally Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme 2.
Quagliata M, Stincarelli M, Papini A, Giannecchini S, Rovero P
ACS Omega. 2023; 8(25):22665-22672.
PMID: 37387789
PMC: 10275481.
DOI: 10.1021/acsomega.3c01436.
Development of the Commercial Manufacturing Process for Nirmatrelvir in 17 Months.
Allais C, Connor C, Do N, Kulkarni S, Lee J, Lee T
ACS Cent Sci. 2023; 9(5):849-857.
PMID: 37252346
PMC: 10069651.
DOI: 10.1021/acscentsci.3c00145.
Recent Advances in Covalent Drug Discovery.
Schaefer D, Cheng X
Pharmaceuticals (Basel). 2023; 16(5).
PMID: 37242447
PMC: 10220821.
DOI: 10.3390/ph16050663.
Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety.
Zhu M, Fu T, You M, Cao J, Yang H, Chen X
Bioorg Med Chem. 2023; 87:117316.
PMID: 37187077
PMC: 10166615.
DOI: 10.1016/j.bmc.2023.117316.
Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir.
Paciaroni A, Libera V, Ripanti F, Orecchini A, Petrillo C, Francisci D
Int J Mol Sci. 2023; 24(7).
PMID: 37047038
PMC: 10093836.
DOI: 10.3390/ijms24076062.
Nitriles: an attractive approach to the development of covalent inhibitors.
Bonatto V, Lameiro R, Rocho F, Lameira J, Leitao A, Montanari C
RSC Med Chem. 2023; 14(2):201-217.
PMID: 36846367
PMC: 9945868.
DOI: 10.1039/d2md00204c.
